Best TWAS P=1.46e-13 · Best GWAS P=1.79e-14 conditioned to 0.0991
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Artery Tibial | AHI1 | 0.11 | 0.03 | enet | 16 | 0.09 | 1.8e-07 | -6.0 | 5.7 | 1.2e-08 | -0.78 | 0.01 | 0.98 | FALSE |
2 | GTEx | Brain Cortex | AHI1 | 0.51 | 0.27 | lasso | 6 | 0.37 | 3.3e-11 | -5.0 | 5.3 | 1.1e-07 | -0.71 | 0.06 | 0.94 | FALSE |
3 | GTEx | Brain Cortex | RP3-388E23.2 | 0.28 | 0.16 | enet | 13 | 0.19 | 5.8e-06 | -2.5 | 5.2 | 2.1e-07 | -0.72 | 0.05 | 0.90 | FALSE |
4 | GTEx | Brain Hippocampus | AHI1 | 0.28 | 0.10 | lasso | 5 | 0.05 | 2.9e-02 | -5.0 | 5.2 | 2.5e-07 | -0.69 | 0.08 | 0.39 | FALSE |
5 | GTEx | Brain Putamen basal ganglia | AHI1 | 0.30 | 0.11 | enet | 36 | 0.12 | 1.0e-03 | -6.9 | 5.3 | 1.4e-07 | -0.69 | 0.05 | 0.80 | FALSE |
6 | GTEx | Cells EBV-transformed lymphocytes | AHI1 | 0.38 | 0.24 | enet | 19 | 0.23 | 5.4e-08 | -6.3 | 7.0 | 1.9e-12 | -0.81 | 0.47 | 0.50 | FALSE |
7 | GTEx | Cells EBV-transformed lymphocytes | RP3-388E23.2 | 0.26 | 0.05 | lasso | 6 | 0.02 | 7.1e-02 | -6.6 | 6.3 | 2.5e-10 | -0.84 | 0.18 | 0.27 | FALSE |
8 | GTEx | Cells Transformed fibroblasts | AHI1 | 0.44 | 0.21 | enet | 22 | 0.32 | 4.4e-24 | -6.9 | 6.2 | 5.4e-10 | -0.75 | 0.44 | 0.56 | FALSE |
9 | GTEx | Esophagus Mucosa | AHI1 | 0.30 | 0.24 | lasso | 8 | 0.32 | 4.6e-22 | -6.6 | 6.1 | 9.2e-10 | -0.74 | 0.82 | 0.18 | FALSE |
10 | GTEx | Lung | TBPL1 | 0.15 | 0.00 | enet | 19 | 0.00 | 4.0e-01 | 4.9 | 6.1 | 1.2e-09 | -0.06 | 0.01 | 0.70 | TRUE |
11 | GTEx | Skin Not Sun Exposed Suprapubic | AHI1 | 0.41 | 0.31 | lasso | 7 | 0.40 | 9.1e-24 | -6.6 | 6.0 | 2.1e-09 | -0.77 | 0.81 | 0.19 | FALSE |
12 | GTEx | Skin Sun Exposed Lower leg | AHI1 | 0.33 | 0.22 | enet | 14 | 0.34 | 1.0e-28 | -2.5 | 5.3 | 1.1e-07 | -0.66 | 0.99 | 0.01 | FALSE |
13 | GTEx | Small Intestine Terminal Ileum | AHI1 | 0.51 | 0.01 | enet | 19 | 0.06 | 2.0e-02 | -6.6 | 5.8 | 5.0e-09 | -0.67 | 0.06 | 0.22 | FALSE |
14 | GTEx | Spleen | AHI1 | 0.31 | 0.21 | lasso | 3 | 0.38 | 8.6e-11 | -3.4 | 5.4 | 6.8e-08 | -0.68 | 0.18 | 0.53 | FALSE |
15 | GTEx | Testis | AHI1 | 0.37 | 0.32 | enet | 25 | 0.37 | 3.5e-17 | -6.6 | 6.3 | 3.2e-10 | -0.74 | 0.79 | 0.21 | FALSE |
16 | METSIM | Adipose | AHI1 | 0.25 | 0.22 | lasso | 7 | 0.28 | 1.1e-42 | -6.3 | 6.5 | 6.7e-11 | -0.81 | 0.30 | 0.70 | FALSE |
17 | NTR | Blood | AHI1 | 0.11 | 0.14 | lasso | 6 | 0.15 | 3.2e-47 | -6.6 | 6.8 | 1.0e-11 | -0.85 | 0.70 | 0.30 | FALSE |
18 | YFS | Blood | AHI1 | 0.24 | 0.30 | bslmm | 414 | 0.33 | 1.4e-110 | -6.6 | 6.3 | 2.9e-10 | -0.77 | 0.84 | 0.16 | FALSE |
19 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | SLC2A12 | 0.07 | 0.06 | enet | 7 | 0.05 | 6.4e-05 | -4.7 | -5.6 | 1.8e-08 | -0.01 | 0.01 | 0.95 | TRUE |
20 | The Cancer Genome Atlas | Breast Invasive Carcinoma | AHI1 | 0.06 | 0.02 | lasso | 7 | 0.02 | 1.3e-04 | -6.6 | 5.7 | 9.1e-09 | -0.73 | 0.00 | 1.00 | FALSE |
21 | The Cancer Genome Atlas | Breast Invasive Carcinoma | C6orf217 | 0.02 | 0.02 | blup | 80 | 0.02 | 1.2e-05 | -6.8 | 7.4 | 1.5e-13 | -0.88 | 0.01 | 0.99 | TRUE |
22 | The Cancer Genome Atlas | Breast Invasive Carcinoma | TCF21 | 0.04 | 0.01 | blup | 40 | 0.02 | 9.9e-06 | -4.4 | 5.8 | 5.6e-09 | -0.05 | 0.01 | 0.92 | TRUE |
23 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | AHI1 | 0.06 | 0.08 | blup | 73 | 0.06 | 1.1e-03 | -6.6 | 5.3 | 1.3e-07 | -0.67 | 0.00 | 0.98 | FALSE |
24 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | AHI1 | 0.18 | 0.19 | lasso | 4 | 0.18 | 6.4e-20 | -6.6 | 6.4 | 1.2e-10 | -0.82 | 0.00 | 1.00 | FALSE |
25 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | SLC2A12 | 0.08 | 0.03 | enet | 8 | 0.04 | 3.5e-05 | 3.3 | -5.4 | 5.4e-08 | -0.01 | 0.01 | 0.96 | FALSE |
26 | The Cancer Genome Atlas | Brain Lower Grade Glioma | AHI1 | 0.03 | 0.02 | enet | 7 | 0.01 | 8.1e-03 | -6.6 | 6.6 | 3.7e-11 | -0.79 | 0.00 | 0.97 | FALSE |
27 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | AHI1 | 0.13 | 0.16 | lasso | 3 | 0.16 | 1.2e-17 | -6.6 | 6.4 | 1.6e-10 | -0.80 | 0.00 | 1.00 | FALSE |
28 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | C6orf217 | 0.04 | 0.03 | blup | 81 | 0.01 | 1.7e-02 | -6.3 | 7.0 | 2.1e-12 | -0.84 | 0.01 | 0.95 | FALSE |
29 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | AHI1 | 0.05 | 0.05 | lasso | 1 | 0.04 | 1.5e-03 | -6.3 | 6.3 | 2.9e-10 | -0.82 | 0.00 | 0.96 | FALSE |
30 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | C6orf217 | 0.06 | 0.06 | enet | 9 | 0.07 | 1.6e-05 | -6.9 | 7.0 | 2.3e-12 | -0.91 | 0.01 | 0.99 | FALSE |
31 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | C6orf217 | 0.10 | 0.00 | blup | 82 | 0.04 | 6.8e-03 | -6.8 | 6.9 | 5.2e-12 | -0.83 | 0.02 | 0.53 | FALSE |
32 | The Cancer Genome Atlas | Prostate Adenocarcinoma | C6orf217 | 0.07 | 0.07 | blup | 81 | 0.09 | 4.3e-10 | -5.1 | 6.1 | 1.4e-09 | -0.62 | 0.21 | 0.79 | FALSE |
33 | The Cancer Genome Atlas | Stomach Adenocarcinoma | C6orf217 | 0.06 | 0.02 | lasso | 3 | 0.02 | 7.7e-03 | -7.7 | 6.7 | 2.1e-11 | -0.92 | 0.00 | 0.88 | FALSE |
34 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | AHI1 | 0.36 | 0.30 | lasso | 3 | 0.29 | 1.0e-10 | -6.3 | 6.2 | 7.3e-10 | -0.81 | 0.00 | 1.00 | FALSE |
35 | The Cancer Genome Atlas | Thyroid Carcinoma | C6orf217 | 0.30 | 0.24 | enet | 16 | 0.26 | 1.5e-25 | -4.3 | 5.2 | 2.3e-07 | -0.64 | 1.00 | 0.00 | FALSE |